Chimeric HBcAg virus-like particles presenting a HPV 16 E7 epitope significantly suppressed tumor progression through preventive or therapeutic immunization in a TC-1-grafted mouse model

References

• ParkinDMBrayFFerlayJPisaniPGlobal cancer statistics, 2002CA Cancer J Clin20055527410815761078
   PubMed Web of Science ®Google Scholar
• BolhassaniAMohitERafatiSDifferent spectra of therapeutic vaccine development against HPV infectionsHum Vaccin200951067168919684468
   PubMed Web of Science ®Google Scholar
• HungCFMaBMonieATsenSWWuTCTherapeutic human papillomavirus vaccines: current clinical trials and future directionsExpert Opin Biol Ther20088442143918352847
   PubMed Web of Science ®Google Scholar
• zur HausenHPapillomaviruses and cancer: from basic studies to clinical applicationNat Rev Cancer20022534235012044010
   PubMed Web of Science ®Google Scholar
• BerzofskyJAAhlersJDJanikJProgress on new vaccine strategies against chronic viral infectionsJ Clin Invest2004114445046215314679
   PubMed Web of Science ®Google Scholar
• MeliefCJvan HallTArensROssendorpFvan der BurgSHTherapeutic cancer vaccinesJ Clin Invest201512593401341226214521
   PubMed Web of Science ®Google Scholar
• WiekingBGVermeerDWSpanosWCA non-oncogenic HPV 16 E6/E7 vaccine enhances treatment of HPV expressing tumorsCancer Gene Ther2012191066767422918471
   PubMed Web of Science ®Google Scholar
• JungIDShinSJLeeMGEnhancement of tumor-specific T cell-mediated immunity in dendritic cell-based vaccines by Mycobacterium tuberculosis heat shock protein XJ Immunol201419331233124524990079
   PubMed Web of Science ®Google Scholar
• SmithKAMeisenburgBLTamVLLymph node-targeted immunotherapy mediates potent immunity resulting in regression of isolated or metastatic human papillomavirus-transformed tumorsClin Cancer Res200915196167617619789304
   PubMed Web of Science ®Google Scholar
• ManuriPRNeheteBNehetePNIntranasal immunization with synthetic peptides corresponding to the E6 and E7 oncoproteins of human papillomavirus type 16 induces systemic and mucosal cellular immune responses and tumor protectionVaccine200725173302331017291642
   PubMed Web of Science ®Google Scholar
• SongYCChengHYLengCHA novel emulsion-type adjuvant containing CpG oligodeoxynucleotides enhances CD8+ T-cell-mediated anti-tumor immunityJ Control Release201417315816524177312
   PubMed Web of Science ®Google Scholar
• LinYCLouPJYoungTHChitosan as an adjuvant-like substrate for dendritic cell culture to enhance antitumor effectsBiomaterials201435318867887525073569
   PubMed Web of Science ®Google Scholar
• BirnbaumFNassalMHepatitis B virus nucleocapsid assembly: primary structure requirements in the core proteinJ Virol1990647331933302191149
   PubMed Web of Science ®Google Scholar
• LeeBOTuckerAFrelinLInteraction of the hepatitis B core antigen and the innate immune systemJ Immunol2009182116670668119454661
   PubMed Web of Science ®Google Scholar
• PumpensPGrensEHBV core particles as a carrier for B cell/T cell epitopesIntervirology2001442–39811411509871
   PubMed Web of Science ®Google Scholar
• MaYHalaykoAJBasuSSustained suppression of IL-13 by a vaccine attenuates airway inflammation and remodeling in miceAm J Respir Cell Mol Biol201348554054923470628
   PubMed Web of Science ®Google Scholar
• LongQHuangWYaoYVirus-like particles presenting interleukin-33 molecules: immunization characteristics and potentials of blocking IL-33/ST2 pathway in allergic airway inflammationHum Vaccin Immunother20141082303231125424936
   PubMed Web of Science ®Google Scholar
• MaYHayGlassKTBeckerABNovel recombinant interleukin-13 peptide-based vaccine reduces airway allergic inflammatory responses in miceAm J Respir Crit Care Med2007176543944517556715
   PubMed Web of Science ®Google Scholar
• GuanQMaYAboudLTargeting IL-23 by employing a p40 peptide-based vaccine ameliorates murine allergic skin and airway inflammationClin Exp Allergy20124291397140522925326
   PubMed Web of Science ®Google Scholar
• GuanQMaYHillmanCLDevelopment of recombinant vaccines against IL-12/IL-23 p40 and in vivo evaluation of their effects in the downregulation of intestinal inflammation in murine colitisVaccine200927507096710419786142
   PubMed Web of Science ®Google Scholar
• ConniotJSilvaJMFernandesJGCancer immunotherapy: nanodelivery approaches for immune cell targeting and trackingFront Chem2014210525505783
   PubMed Web of Science ®Google Scholar
• WynneSACrowtherRALeslieAGThe crystal structure of the human hepatitis B virus capsidMol Cell19993677178010394365
   PubMed Web of Science ®Google Scholar
• SominskayaISkrastinaDPetrovskisIA VLP library of C-terminally truncated hepatitis B core proteins: correlation of RNA encapsidation with a Th1/Th2 switch in the immune responses of micePLoS One201389e7593824086668
   PubMed Web of Science ®Google Scholar
• GrassoFNegriDRMochiSSuccessful therapeutic vaccination with integrase defective lentiviral vector expressing nononcogenic human papillomavirus E7 proteinInt J Cancer2013132233534422700466
   PubMed Web of Science ®Google Scholar
• SzaboSJSullivanBMPengSLGlimcherLHMolecular mechanisms regulating Th1 immune responsesAnnu Rev Immunol20032171375812500979
   PubMed Web of Science ®Google Scholar
• TauGZvon der WeidTLuBInterferon gamma signaling alters the function of T helper type 1 cellsJ Exp Med2000192797798611015439
   PubMed Web of Science ®Google Scholar
• HallettMAVenmarKTFingletonBCytokine stimulation of epithelial cancer cells: the similar and divergent functions of IL-4 and IL-13Cancer Res201272246338634323222300
   PubMed Web of Science ®Google Scholar
• DrabschYten DijkePTGF-beta signalling and its role in cancer progression and metastasisCancer Metastasis Rev2012313–455356822714591
   PubMed Web of Science ®Google Scholar
• MoustakasAHeldinCHInduction of epithelial-mesenchymal transition by transforming growth factor betaSemin Cancer Biol2012225–644645422548724
   PubMed Web of Science ®Google Scholar